Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Neural Transmission - Parkinsons Disease and Dementia Section

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02260965PMID 7710663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

  2005cited by this paper
• Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.

  1993cited by this paper
• Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis.

  1993influential reference
• 123I‐iodobenzamide‐SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism

  1992cited by this paper
• A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains

  1992cited by this paper
• New insights into the cause of Parkinson's disease

  1992cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Iron induces degeneration of nigrostriatal neurons.

  1992cited by this paper
• Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease

  1992cited by this paper
• Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

  1991cited by this paper
• Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

  1991cited by this paper
• Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.

  1991cited by this paper
• Dopa and dopamine cause cultured neuronal death in the presence of iron.

  1991cited by this paper
• Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

  1991cited by this paper
• Decreased Ferritin Levels in Brain in Parkinson's Disease

  1990cited by this paper
• Ferritin in the cerebrospinal fluid of patients with Parkinson's disease.

  1990cited by this paper
• Brain iron and ferritin in Parkinson's and Alzheimer's diseases

  1990cited by this paper
• Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

  1989cited by this paper
• Regional Metal Concentrations in Parkinson's Disease, Other Chronic Neurological Diseases, and Control Brains

  1989cited by this paper
• Multiple system atrophy--the nature of the beast.

  1989cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.)

  1988cited by this paper
• Biochemical fundamentals of Parkinson's disease.

  1988cited by this paper
• Raised cerebrospinal-fluid copper concentration in Parkinson's disease.

  1987cited by this paper
• Increased nigral iron content in postmortem parkinsonian brain.

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Sub-Chronic 30 mg/kg Iron Treatment Induces Spatial Cognition Impairment and Brain Oxidative Stress in Wistar Rats

  2025cites this paper
• Modifiable chemical risk factors for amyloid-β and Tau protein in Alzheimer's disease.

  2025cites this paper
• Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs.

  2025cites this paper
• Iron homeostasis and post-hemorrhagic hydrocephalus: a review

  2024cites this paper
• Causal Relationship Between Ferritin and Neuropsychiatric Disorders: A Two-Sample Mendelian Randomization Study

  2024cites this paper
• Peripheral Blood Immune Cells from Individuals with Parkinson’s Disease or Inflammatory Bowel Disease Share Deficits in Iron Storage and Transport that are Modulated by Non-Steroidal Anti-Inflammatory Drugs

  2024cites this paper
• The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects.

  2024cites this paper
• [Ferritin as a biomarker of aging: geroprotective peptides of standardized human placental hydrolysate. A review].

  2024cites this paper
• Brain Iron Metabolism, Redox Balance and Neurological Diseases

  2023cites this paper
• Exposure of metal toxicity in Alzheimer’s disease: An extensive review

  2022cites this paper
• Ependymal cells and neurodegenerative disease: outcomes of compromised ependymal barrier function

  2022cites this paper
• The clinical applications of ferritin

  2022cites this paper
• Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities

  2022cites this paper
• How Do Abnormalities in the Cerebrospinal Fluid Impact Neuropsychology with Progressing Age?

  2022cites this paper
• New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases

  2021cites this paper
• Direct detection of iron clusters in L ferritins through ESI-MS experiments.

  2021cites this paper
• Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

  2021cites this paper
• Chemistry and Biology of Ferritin

  2021cites this paper
• Biological fluid levels of iron and iron‐related proteins in Parkinson’s disease: Review and meta‐analysis

  2020cites this paper
• Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease

  2020cites this paper
• Elevated serum ferritin level as a predictor of reduced survival in patients with sporadic amyotrophic lateral sclerosis in China: a retrospective study

  2019cites this paper
• Emerging and Dynamic Biomedical Uses of Ferritin

  2018cites this paper
• The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint

  2018cites this paper
• Analysis of neurotrophic and antioxidant factors related to midbrain dopamine neuronal loss and brain inflammation in the cerebrospinal fluid of the elderly

  2018cites this paper
• The mechanism of action of clioquinol for the treatment of Alzheimer's disease

  2018cites this paper
• Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

  2016cites this paper
• The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update

  2016cites this paper
• Iron chelation in the treatment of neurodegenerative diseases.

  2016cites this paper
• Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

  2015cites this paper
• Les marqueurs biologiques de l'atrophie multisystématisée

  2014cites this paper
• Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

  2014cites this paper
• Cerebrospinal fluid biomarkers for neurodegenerative disorders

  2013cites this paper
• Copper and iron in Alzheimer's disease: a systematic review and its dietary implications

  2011cites this paper
• A possible role for secreted ferritin in tissue iron distribution

  2011cites this paper
• Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach

  2010influential citation
• Neurochemical biomarkers in the differential diagnosis of movement disorders

  2009cites this paper
• Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.

  2009cites this paper
• A new rodent model of Parkinson s Disease based on neuron specific downregulation of glutathione production.

  2009cites this paper
• Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease

  2008cites this paper
• Biomarkers for Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Possible mechanisms mediating neurodegeneration

  2007cites this paper
• Ferritin subunits in CSF are decreased in restless legs syndrome.

  2006cites this paper
• Neurodegenerative Diseases: An Overview of Environmental Risk Factors

  2005influential citation
• Oxidation-induced ferritin turnover in microglial cells: role of proteasome.

  2005cites this paper
• Molecular study of cell culture models of Parkinson's disease and Huntington's disease.

  2005cites this paper
• BRAIN IRON DEFICIENCY IN HUMANS AND ANIMAL MODELS

  2005cites this paper
• Oxidative stress in Parkinson's disease

  2003cites this paper
• Are hereditary hemochromatosis mutations involved in Alzheimer disease?

  2000cites this paper
• Peripheral Markers of Alzheimer’s

  2000cites this paper
• A unifying hypothesis of Alzheimer's disease. III. Risk factors

  2000cites this paper
• Early Diagnosis of Alzheimer’s Disease

  2000cites this paper
• Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.

  1999cites this paper
• [Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study].

  1999cites this paper
• Neue Behandlungsansätze bei der Alzheimer-Demenz

  1999cites this paper
• Biological markers for the diagnosis of Alzheimer's disease.

  1998cites this paper
• Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged.

  1998cites this paper
• [Alzheimer disease, markers in the cerebrospinal fluid. Support of physiopathologic hypotheses].

  1998cites this paper
• Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease

  1998cites this paper
• Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease

  1998cites this paper
• Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes.

  1997cites this paper
• Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders

  1996cites this paper
• Ferritin Levels in the Cerebrospinal Fluid Predict Alzheimer's Disease Outcomes and Are Regulated by Apoe

  year unknowncites this paper